阿替利珠单抗治疗化疗进展后晚期非小细胞肺癌的成本效用分析*

张川,冉凤林,顾凌寒,刘悦,田攀文,李为民

Cost-utility Analysis of Atezolizumab in the Second-Line Treatment of Metastatic Non-Small Cell Lung Cancer

Chuan ZHANG,Fenglin RAN,Linghan GU,Yue LIU,Panwen TIAN,Weimin LI

图1 单因素敏感性分析旋风图

Fig.1 Tornado diagram of 1-way sensitivity analysis